ArticleJournal of clinical laboratory analysis2022

Low-level EFCAB1 promoted progress by upregulated DNMT3B and could be as a potential biomarker in lung adenocarcinoma.

Xiang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.